NCT06242119
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +20 more
- Locations
-
- Department of Endocrinology and Nuclear Medicine, University Hospital in Krakow Krakow, Poland
Clinical trial condition
Carcinoma, Neuroendocrine
Explore clinical trials studying Carcinoma, Neuroendocrine. Study availability and eligibility vary by location and protocol.
112 public trials
35 recruiting studies
Carcinoma, Neuroendocrine trial results
NCT06440057
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- Chinese PLA General Hospital Beijing, Beijing Municipality, China
NCT06372626
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- Chinese PLA General Hospital Beijing, Beijing Municipality, China
NCT06369181
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +19 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT06337760
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- European Institute of Oncology Milan, Italy
Not yet recruiting
ZG005 Plus Etoposide and Cisplatin vs. Etoposide and Cisplatin as First-Line Treatment for Advanced Neuroendocrine Carcinoma
NCT07833839
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
Not yet recruiting
A Trial for the Treatment of Advanced Large-Cell Neuroendocrine Cancer of the Lung
NCT07561645
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +14 more
- Locations
-
Not specified
Not yet recruiting
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
NCT06941480
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +11 more
- Locations
-
- Memorial Sloan Kettering Cancer Center Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities ) Commack, New York, United States
Not yet recruiting
TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors
NCT07713732
- Conditions
- Adenocarcinoma, Adenoma, Bronchial Neoplasms, +33 more
- Locations
-
- COBL Clinical Trials - Chris O'Brien Lifehouse Camperdown, New South Wales, Australia
- Cabrini Hospital Malvern Malvern, Victoria, Australia
- Linear Clinical Research Nedlands, Western Australia, Australia
Not yet recruiting
AK112 Combination Therapy as First Line Treatment for Metastatic Digestive System Neuroendocrine Cancer
NCT07712094
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +8 more
- Locations
-
- Baotou Cancer Hospital Baotou, Inner Mongolia, China
- The First People's Hospital of Horqin District, Tongliao City Tongliao, Inner Mongolia, China
- Shanxi Bethune Hospital Taiyuan, Shanxi, China
- Tianjin First Central Hospital Tianjin, China